In response to growing operational needs, CHIL transitioned into a 1,000 m² manufacturing facility. This move marked a strategic shift from early stage production to scalable industrial capacity.
In February 2017, CHIL participated in Medlab Middle East, Dubai.
In April 2017, CHIL participated in MEDLAB Asia Pacific.
In November 2017, CHIL conducted on-site technical training and laboratory visits in Saudi Arabia, supporting device integration, kit utilization, and customer implementation processes.
In November 2017, CHIL participated in MEDICA Messe Düsseldorf, Düsseldorf.